NMTC Stock Overview
A developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
NeuroOne Medical Technologies Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.70 |
| 52 Week High | US$2.00 |
| 52 Week Low | US$0.60 |
| Beta | 0.91 |
| 11 Month Change | -23.57% |
| 3 Month Change | -15.15% |
| 1 Year Change | -47.95% |
| 33 Year Change | -69.16% |
| 5 Year Change | -90.28% |
| Change since IPO | -94.17% |
Recent News & Updates
Recent updates
Is NeuroOne Medical Technologies (NASDAQ:NMTC) In A Good Position To Deliver On Growth Plans?
Dec 16
Can NeuroOne Medical Technologies (NASDAQ:NMTC) Afford To Invest In Growth?
Jul 25Here's Why We're Watching NeuroOne Medical Technologies' (NASDAQ:NMTC) Cash Burn Situation
Apr 11We Think NeuroOne Medical Technologies (NASDAQ:NMTC) Needs To Drive Business Growth Carefully
Sep 15NeuroOne rallies on receiving $3.5M in accelerated milestone payment from Zimmer Biomet
Aug 03Is NeuroOne Medical Technologies (NASDAQ:NMTC) In A Good Position To Deliver On Growth Plans?
Jun 02Companies Like NeuroOne Medical Technologies (NASDAQ:NMTC) Could Be Quite Risky
Dec 18NeuroOne: Thin Film Electrodes For Diagnosis And Treatment Of Neurological Conditions
Nov 19Will NeuroOne Medical Technologies (NASDAQ:NMTC) Spend Its Cash Wisely?
Sep 04We're Not Very Worried About NeuroOne Medical Technologies' (NASDAQ:NMTC) Cash Burn Rate
May 27Shareholder Returns
| NMTC | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -22.2% | -0.7% | -2.1% |
| 1Y | -47.9% | 22.5% | 29.7% |
Return vs Industry: NMTC underperformed the US Medical Equipment industry which returned 22.4% over the past year.
Return vs Market: NMTC underperformed the US Market which returned 29.6% over the past year.
Price Volatility
| NMTC volatility | |
|---|---|
| NMTC Average Weekly Movement | 10.3% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: NMTC's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: NMTC's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 16 | Dave Rosa | www.n1mtc.com |
NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator.
NeuroOne Medical Technologies Corporation Fundamentals Summary
| NMTC fundamental statistics | |
|---|---|
| Market cap | US$21.91m |
| Earnings (TTM) | -US$12.10m |
| Revenue (TTM) | US$3.92m |
5.5x
P/S Ratio-1.8x
P/E RatioIs NMTC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NMTC income statement (TTM) | |
|---|---|
| Revenue | US$3.92m |
| Cost of Revenue | US$8.52m |
| Gross Profit | -US$4.60m |
| Other Expenses | US$7.50m |
| Earnings | -US$12.10m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.39 |
| Gross Margin | -117.24% |
| Net Profit Margin | -308.54% |
| Debt/Equity Ratio | 0% |
How did NMTC perform over the long term?
See historical performance and comparison